Key metrics to watch: Assets Under Custody (AUC) growth rate and net deposits—indicates customer retention and wallet share gains · Transaction-based revenue per funded account—measures monetization efficiency · Net interest margin (NIM) and average interest-earning assets—tracks sensitivity to rate environment · VIX Index (CBOE Volatility Index)—trading volumes spike 50-100% when VIX exceeds 25

News

The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ®

businesswire.com

China's record oil output reaches limits of what's possible

reuters.com

Novartis to buy breast cancer drug candidate from Synnovation

reuters.com

Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

benzinga.com

Flex LNG - Notice of Annual General Meeting 2026

prnewswire.com

What if ASML Becomes the Next Trillion-Dollar Stock?

fool.com

Alibaba workforce shrinks 34% in 2025 as Chinese tech giant doubles down on AI

cnbc.com

Geely: Positive On Profit Surge And Favorable Prospects

seekingalpha.com

KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

prnewswire.com

Paysafe Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PSFE

prnewswire.com

BellRing Brands, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BRBR

prnewswire.com

Novartis to Acquire Synnovation Therapeutics' Pan-Mutant Selective PI3Kα Inhibitor Program

businesswire.com

Should You Buy Lockheed Martin Stock Right Now?

fool.com

Tripadvisor: Activist Pressure Supports Our Upside Outlook

seekingalpha.com

Standard Chartered, BSI lose bid to join cases in Singapore winding up firms with assets linked to 1MDB

reuters.com

Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline

globenewswire.com

Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.

globenewswire.com

About

Robinhood Markets, Inc.

CEO

Vladimir Tenev

robinhood.com →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

The Iran war is sending shockwaves through the world's busiest IPO market

Novartis to Buy Breast-Cancer Drug From Synnovation for Up to $3 Billion

Transaction in Own Shares

The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ®

China's record oil output reaches limits of what's possible

Novartis to buy breast cancer drug candidate from Synnovation

Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Flex LNG - Notice of Annual General Meeting 2026

What if ASML Becomes the Next Trillion-Dollar Stock?

Alibaba workforce shrinks 34% in 2025 as Chinese tech giant doubles down on AI

Geely: Positive On Profit Surge And Favorable Prospects

KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Paysafe Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PSFE

BellRing Brands, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BRBR

Novartis to Acquire Synnovation Therapeutics' Pan-Mutant Selective PI3Kα Inhibitor Program

Should You Buy Lockheed Martin Stock Right Now?

Tripadvisor: Activist Pressure Supports Our Upside Outlook

Standard Chartered, BSI lose bid to join cases in Singapore winding up firms with assets linked to 1MDB

Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline

Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.

About

Explore More

The Iran war is sending shockwaves through the world's busiest IPO market

Novartis to Buy Breast-Cancer Drug From Synnovation for Up to $3 Billion

Transaction in Own Shares

The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ®

China's record oil output reaches limits of what's possible

Novartis to buy breast cancer drug candidate from Synnovation

Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Flex LNG - Notice of Annual General Meeting 2026

What if ASML Becomes the Next Trillion-Dollar Stock?

Alibaba workforce shrinks 34% in 2025 as Chinese tech giant doubles down on AI

Geely: Positive On Profit Surge And Favorable Prospects

KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Paysafe Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PSFE

BellRing Brands, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BRBR

Novartis to Acquire Synnovation Therapeutics' Pan-Mutant Selective PI3Kα Inhibitor Program

Should You Buy Lockheed Martin Stock Right Now?

Tripadvisor: Activist Pressure Supports Our Upside Outlook

Standard Chartered, BSI lose bid to join cases in Singapore winding up firms with assets linked to 1MDB

Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline

Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.